Homocysteine levels are associated with hippocampus volume in type 2 diabetic patients

European Journal of Clinical Investigation

Volumn 41, Issue 7, 2011, Pages 751-758

  Shimomura, Tsuyoshi ^a   Anan, Futoshi ^a,b   Masaki, Takayuki ^a   Umeno, Yoshikazu ^b   Eshima, Nobuoki ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a   Fujiki, Minoru ^a   Kobayashi, Hidenori ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

Author keywords

Hippocampus volume; Homocysteine; Insulin resistance; Type 2 diabetes mellitus; Voxel based specific regional analysis system for Alzheimer's disease

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HIPPOCAMPUS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

AGED; BRAIN MAPPING; DIABETES MELLITUS, TYPE 2; FEMALE; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 79958704906     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02464.x     Document Type: Article

References (45)

1. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103:163-82.
2. Hébert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31:1487-93.
3. Reaven GM. Banting. Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
4. Reagan LP. Insulin signaling effects on memory and mood. Curr Opin Pharmacol 2007;7:633-7.
5. den Heijer T, Vermeer SE, van Dijik EJ, Prins ND, Koudstaal PJ, Hofman A et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003;46:1604-10.
6. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002;51:1256-62.
7. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000;107:1469-74.
8. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003;77:668-73.
9. Williams JH, Pereira EA, Budge MM, Bradley KM. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 2002;31:440-4.
10. den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A et al. Homocysteine and brain atrophy in MRI of non-demented elderly. Brain 2003;126:170-5.
11. Press GA, Amaral DG, Squire LR. Hippocampus abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging. Nature 1989;341:54-7.
12. Baxendale S. Amnesia in temporal lobectomy patients: historical perspective and review. Seizure 1988;7:15-24.
13. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998;51:993-9.
14. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci 2000;911:240-53.
15. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
16. Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamashita F et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005;382:269-74.
17. Anan F, Masaki T, Shimomura T, Fujiki M, Umeno Y, Eshima N et al. Abdominal visceral fat accumulation is associated with hippocampal volume in non-dementia patients with type 2 diabetes mellitus. NeuroImage 2010;49:57-62.
18. Giltay EJ, Hoogeveen EK, Elberts JM, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma homocysteine levels in healthy, non-obese subjects. Arteriosclerosis 1998;139:197-8.
19. Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001;24:533-8.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
21. Donnelly JG, Pronovost C. Evaluation of the Abbott IMx fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography. Ann Clin Biochem 2000;37:194-8.
22. Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 2001;24:1805-9.
23. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998;21:2116-22.
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007;25:1751-62.
25. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
26. Ashburner J, Friston K. Multimodal image coregistration and partitioning-a unified framework. NeuroImage 1997;6:209-17.
27. Ashburner J, Friston K. Voxel-based morphometry: the methods. NeuroImage 2000;11:805-21.
28. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrica 1991;78:153-7.
29. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 2005;34:119-26.
30. Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidant stress disrupts insulin-induced redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and glut4 translocation. J Biol Chem 1999;274:10595-602.
31. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling and glutathione has a protective effects. J Mol Endocrinol 2001;27:85-91.
32. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and insulin treatment on homocysteine metabolism rat. Diabetes 1998;47:967-70.
33. Fonseca V, Dicker-Brown A, Ranganathan S, Song W, Barnard RJ, Fink L et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2007;49:736-41.
34. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997;94:5923-8.
35. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002;22:1752-62.
36. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000;20:6920-6.
37. Dore S, Kar S, Rowe W, Quirion R. Distribution and levels of (125I) IGF-I, (125I) IGF-II and (125I) insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience 1997;80:1033-40.
38. Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001;25:311-23.
39. Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 2000;68:509-14.
40. Zhao W, Chen H, Moore E, Moore E, Meiri N, Quon MJ et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem 1999;274:34893-902.
41. McEwen BS, Reagan LP. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004;490:13-24.
42. Young SE, Mainous AG III, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006;29:2688-93.
43. Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, Ramirez LC, Raskin P. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999;12:298-303.
44. Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 2002;164:321-8.
45. Araki R, Maruyama C, Igarashi S, Yoshida M, Maruyama T, Satoh T et al. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects. Eur J Clin Nutr 2006;60:573-9.